Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Inventory Average: 2022-2025

Historic Inventory Average for Axsome Therapeutics (AXSM) over the last 3 years, with Sep 2025 value amounting to $21.1 million.

  • Axsome Therapeutics' Inventory Average rose 43.17% to $21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 43.17%. This contributed to the annual value of $15.4 million for FY2024, which is 58.66% up from last year.
  • Latest data reveals that Axsome Therapeutics reported Inventory Average of $21.1 million as of Q3 2025, which was up 21.45% from $17.4 million recorded in Q2 2025.
  • In the past 5 years, Axsome Therapeutics' Inventory Average ranged from a high of $21.1 million in Q3 2025 and a low of $6.1 million during Q1 2023.
  • Over the past 3 years, Axsome Therapeutics' median Inventory Average value was $15.0 million (recorded in 2024), while the average stood at $13.8 million.
  • As far as peak fluctuations go, Axsome Therapeutics' Inventory Average declined by 20.87% in 2023, and later surged by 150.55% in 2024.
  • Over the past 4 years, Axsome Therapeutics' Inventory Average (Quarterly) stood at $9.2 million in 2022, then spiked by 37.21% to $12.6 million in 2023, then rose by 19.41% to $15.0 million in 2024, then surged by 43.17% to $21.1 million in 2025.
  • Its last three reported values are $21.1 million in Q3 2025, $17.4 million for Q2 2025, and $16.0 million during Q1 2025.